Behind the science
6 in 10 of adults over 50 have never heard of RSV, despite some being most at risk
A leading cause of respiratory illness in adults, it is estimated to cause more than 5 million infections and 33,000 in-hospital deaths in over 60s every year. However, of the 3516 adults surveyed by GSK ahead of RSV Awareness Week, 60% were unaware of virus. Find out more below.
Our purpose
We are a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.Our R&D focus is on four therapeutic areas: infectious diseases, HIV, immunology/respiratory and oncology
Behind the science